Dragonfly's novel Cytokine and TriNKET® immune engagers work in autoimmune disease, oncology, neuro-inflammation and other disease areas, directly and indirectly harnessing NK cells, CD8+ T cells and gd T cells to kill disease targets, and improving the outcomes of other immunotherapy approaches like T-cell therapies.